Share Price:

APNASPENAspen Pharmacare Hldgs10905-20 (-0.18%)

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

Aspen records 15% year-on-year revenue increase

Johannesburg – JSE listed Aspen (Apn), Africa’s largest pharmaceutical manufacturer, has recorded consistently positive results for the period ended December 2007. Revenue increased by 15 percent to R2.2 billion (R1.9 billion). Operating profit increased by 24 percent to R634 million (R 512 million). Earnings per share increased by 31 percent to 125.0 cents (95.3 cents).… Continue reading Aspen records 15% year-on-year revenue increase

Closed Period

Aspen is in a closed period from 1st January 2026 until the publication of the interim results on the JSE SENS platform on the 3rd March 2026.

The live presentation will take place in Cape Town at 08h30 on 2 March 2023.

Corporate

Our career opportunities are across the corporate spectrum, including Human Capital, Digital Technology, Legal, and Risk & Sustainability. Our employees are given the opportunity to hone their skills and develop the experience of excellence in their chosen field in the pharmaceutical industry.

View our teams below: